|
Merck, Schering-Plough to join forces to marry four drugs.
Publication: The Philadelphia Inquirer (via Knight-Ridder/Tribune News Service) Publication Date: 23-MAY-00 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2000 The Philadelphia Inquirer
Byline: Susan Warner
Pharmaceutical competitors Merck & Co. and Schering-Plough Corp. said Tuesday they will join forces to create new heart and respiratory drugs by marrying aging powerhouses, Zocor and Claritin, with two newcomers.
The New Jersey companies said they plan to seek government approval to sell a new pill that would combine Merck's cholesterol-lowering drug Zocor with ezetimibe, a cholesterol absorption inhibitor under development by Schering-Plough.
The partnership would also combine Schering-Plough's blockbuster antihistamine Claritin with Singulair, which reduces asthma inflammation and was launched by Merck in 1998.
The combination strategy would give patients a double whammy of medicine in a...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from The Philadelphia Inquirer (via Knight-Ridder/Tribune News Service) |
Names in the news.
May 23, 2000
|
Hillary has nothing wrapped up.
May 23, 2000
|
The AIDS crisis and South Africa.
May 23, 2000
|
WUSA, MLS strike deal for pro league.
May 23, 2000
|
Is football making a pass at Limbaugh or just fumbling?
May 23, 2000
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
